S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
SRTA · Strata Critical Medical, Inc. Class A
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Strata Critical Medical Inc (SRTA)
NASDAQ NMS - GLOBAL MARKET
Health Care
$4.74
+0.04
(+0.85%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$4.74
$4.65
$4.79
52-WEEK RANGE
$4.74
$3.95
$6.50
What's happening
- SRTA is up 0.85% today, trading at $4.74. — Live quote
- Volume today (74,792) is well below its 3-month average of 1,043,110. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 18 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.12 actual vs. $0.01 estimated (-1619.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 6
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (10 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
SRTA
-2.49%
vs S&P 500
-15.27%
1-YEAR RETURN
SRTA
-9.98%
vs S&P 500
-24.54%
6-MONTH RETURN
SRTA
+4.22%
3-MONTH RETURN
SRTA
-9.11%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.12
Est. $0.01
MISS -1619.0%
2026-04-26 (Q1 2026)
$0.03
Est. $-0.04
BEAT +178.3%
2026-01-26 (Q4 2025)
$-0.12
Est. $-0.03
MISS -370.6%
2025-10-26 (Q3 2025)
$-0.05
Est. $-0.03
MISS -96.1%
Valuation Measures & Ratios
Enterprise Value4$398.6M
Forward P/E5209.33
PEG Ratio6—
Price / Sales (TTM1)1.62
Price / Book71.63
EV4 / Revenue1.56
EV4 / EBITDA—
Profit Margin15.71%
Operating Margin-7.97%
Return on Equity (ROE8)14.27%
Return on Assets (ROA9)12.18%
Avg Volume (3M)1,043,110
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $461.8M | $300.1M | $414.2M | $301.7M | $237.5M |
| P/E | 10.19 | 5.73 | 8.59 | -14.70 | -11.31 |
| Price/Sales | 1.97 | 1.52 | 2.49 | 1.63 | 1.24 |
| Price/Book | 1.65 | 1.05 | 1.46 | 1.35 | 1.08 |
| EV/Revenue | 1.90 | 1.22 | 2.35 | 1.31 | 1.06 |
| EV/EBITDA | -124.10 | -22.59 | -26.05 | — | — |
| ROE | 16.22% | 18.32% | 17.04% | -9.20% | -9.56% |
| ROA | 13.62% | 15.97% | 14.39% | -7.95% | -8.38% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short4,331,692
Change from Prior Settlement-0.62%
% of Float—
Days to Cover (Short Ratio)6.07
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 2.4% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 15.7%. Finnhub fundamentals ↗
Potential concerns
- Trailing 52-week price return is -10.0%. Finnhub market metrics ↗
- Latest SEC filing is Form 4, filed 2026-09-25; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on SRTA
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $72.5M | $67.4M | $49.3M | $45.1M | $35.9M | $36.1M | $67.9M | $51.5M |
| Gross profit | $15.2M | $14.1M | — | $9.0M | $7.1M | — | — | — |
| Operating income | -$5.4M | -$3.0M | -$5.6M | -$4.6M | -$5.7M | -$7.1M | -$12.1M | -$9.9M |
| Net income | -$10.5M | $2.2M | $57.4M | -$3.7M | -$3.5M | -$2.0M | -$11.3M | -$4.2M |
| EPS (diluted) | $-0.12 | $0.03 | $0.70 | $-0.05 | $-0.04 | $-0.03 | $-0.15 | $-0.06 |
| EPS (basic) | $-0.12 | $0.03 | $0.70 | $-0.05 | $-0.04 | $-0.03 | $-0.15 | $-0.06 |
| Operating margin | -$7 | -$4 | -$11 | -$10 | -$16 | -$20 | -$18 | -$19 |
| Net margin | -$15 | $3 | $116 | -$8 | -$10 | -$5 | -$17 | -$8 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $332.7M | $327.6M | $325.5M | $335.1M | $257.9M | $250.6M | $256.7M | $282.9M |
| Total liabilities | $53.4M | $41.9M | $46.4M | $52.1M | $34.8M | $30.8M | $34.7M | $49.4M |
| Stockholders' equity | $279.3M | $285.7M | $279.1M | $283.0M | $223.1M | $219.7M | $221.9M | $233.5M |
| Total current assets | $121.0M | $124.1M | $126.2M | $122.5M | $156.5M | $152.3M | $160.7M | $171.8M |
| Total current liabilities | $45.8M | $20.9M | $19.8M | $27.9M | $26.3M | $21.9M | $22.7M | $27.2M |
| Cash & equivalents | $16.3M | $58.7M | $31.0M | $22.8M | $58.8M | $34.8M | $18.4M | $20.0M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $43.4M | $39.6M | $40.0M | $37.5M | $28.2M | $22.1M | $19.8M | $24.5M |
| Other current assets | $6.3M | $6.2M | $5.0M | — | — | — | $509.0K | — |
| Marketable securities (non-current) | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $40.7M | $40.1M | $36.4M | $38.6M | $33.7M | $32.6M | $28.5M | $30.6M |
| Goodwill | $106.9M | $88.6M | $88.2M | $84.6M | $44.3M | $42.0M | $15.5M | $43.0M |
| Intangible assets | $60.0M | $46.3M | $47.5M | $49.8M | $13.6M | $13.5M | $8.0M | $14.0M |
| Other non-current assets | $90.0K | $24.3M | $24.0M | $8.6M | $1.5M | $1.5M | $118.0K | $913.0K |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | — | — | — | — | $9.1M | $8.0M | $6.7M | $6.7M |
| Other current liabilities | $26.3M | — | $0 | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $4.1M | $17.1M | $22.1M | $18.3M | — | — | $0 | — |
| Common stock & paid-in capital | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K |
| Retained earnings | -$153.9M | -$143.4M | -$145.6M | -$136.7M | -$194.1M | -$190.4M | -$186.9M | -$177.1M |
| Accumulated other comprehensive income (loss) | $0 | $0 | $0 | $0 | $6.0M | $3.1M | $1.8M | $4.2M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.7M | $3.9M | -$8.3M | -$37.3M | -$3.1M | -$246.0K | -$1.8M | $6.4M |
| Investing cash flow | -$43.9M | $24.7M | $18.3M | $2.4M | $28.7M | $20.4M | $4.0M | -$12.6M |
| Financing cash flow | -$4.2M | -$859.0K | -$1.7M | -$1.8M | -$1.1M | -$4.2M | -$3.9M | -$731.0K |
| Free cash flow | $3.2M | -$1.3M | -$10.2M | -$40.2M | -$5.3M | -$2.9M | -$6.3M | -$3.0M |
| Capital expenditures | $2.5M | $5.2M | $1.8M | $2.9M | $2.2M | $2.6M | $4.6M | $9.3M |
| Depreciation & amortization | $8.5M | $3.1M | $3.0M | $1.7M | $1.8M | $1.7M | $1.5M | $2.8M |
| Share-based compensation | $3.7M | $5.0M | $6.6M | $1.7M | $5.3M | $4.2M | $4.5M | $5.4M |
| Deferred income taxes | -$19.0K | -$77.0K | -$126.0K | $554.0K | $21.0K | -$17.0K | -$105.0K | -$118.0K |
| Change in accounts receivable | $666.0K | -$149.0K | $3.5M | $1.8M | $6.3M | $520.0K | -$2.6M | -$3.4M |
| Sales/maturities of investments | — | — | $0 | $70.2M | — | — | $0 | $0 |
| Share repurchases | — | — | $0 | $0 | $0 | — | $0 | $0 |
| Tax withholding on stock comp | $4.2M | $582.0K | $1.8M | $1.9M | $1.2M | $4.3M | $3.9M | $742.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Sep '21 |
|---|---|---|---|---|---|
| Revenue | $197.1M | $146.8M | $225.2M | $146.1M | $50.5M |
| Gross profit | $41.1M | $29.6M | — | — | — |
| Operating income | -$22.4M | -$22.5M | -$68.1M | -$53.5M | -$24.1M |
| Net income | $41.3M | -$27.3M | -$56.1M | -$27.3M | -$40.1M |
| EPS (diluted) | $0.50 | $-0.35 | $-0.76 | $-0.38 | $-0.93 |
| EPS (basic) | $0.50 | $-0.35 | $-0.76 | $-0.38 | $-0.93 |
| Operating margin | -$11 | -$15 | -$30 | -$37 | -$48 |
| Net margin | $21 | -$19 | -$25 | -$19 | -$79 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $325.5M | $256.7M | $294.9M | $325.0M | $335.9M |
| Total liabilities | $46.4M | $34.7M | $60.6M | $50.5M | $44.5M |
| Stockholders' equity | $279.1M | $221.9M | $234.3M | $274.5M | $291.4M |
| Total current assets | $126.2M | $160.7M | $206.3M | $218.1M | $294.9M |
| Total current liabilities | $19.8M | $22.7M | $35.5M | $26.6M | $12.8M |
| Cash & equivalents | $31.0M | $18.4M | $27.9M | $41.3M | $2.6M |
| Accounts receivable | $40.0M | $19.8M | $21.0M | $10.9M | $5.5M |
| Other current assets | $5.0M | $509.0K | — | — | — |
| Marketable securities (non-current) | — | — | — | — | — |
| Property, plant & equipment | $36.4M | $28.5M | $2.9M | $2.0M | $2.0M |
| Goodwill | $88.2M | $15.5M | $13.3M | $39.4M | $13.3M |
| Intangible assets | $47.5M | $8.0M | $20.5M | $46.4M | $24.4M |
| Other non-current assets | $24.0M | $118.0K | $1.4M | $1.4M | $232.0K |
| Accrued liabilities | — | — | — | — | — |
| Deferred revenue (current) | — | $6.7M | $6.8M | $6.7M | $6.0M |
| Long-term debt | — | — | — | $0 | — |
| Other non-current liabilities | $22.1M | $0 | — | — | — |
| Common stock & paid-in capital | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K |
| Retained earnings | -$145.6M | -$186.9M | -$159.8M | -$103.7M | -$76.4M |
| Accumulated other comprehensive income (loss) | $0 | $1.8M | $4.0M | $2.3M | -$898.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Sep '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$48.9M | -$2.5M | -$32.3M | -$37.1M | -$15.6M |
| Investing cash flow | $69.8M | -$1.0M | $17.1M | $79.3M | -$321.3M |
| Financing cash flow | -$8.9M | -$5.8M | -$76.0K | -$1.1M | $332.3M |
| Free cash flow | -$58.5M | -$33.4M | -$34.5M | -$37.9M | -$15.9M |
| Capital expenditures | $9.6M | $30.9M | $2.1M | $730.0K | $297.0K |
| Depreciation & amortization | $8.2M | $6.0M | $7.1M | $5.7M | $596.0K |
| Share-based compensation | $17.8M | $19.9M | $12.5M | $8.3M | $9.6M |
| Deferred income taxes | $432.0K | -$255.0K | -$1.5M | -$772.0K | -$3.6M |
| Change in accounts receivable | $12.0M | $998.0K | $10.3M | $5.3M | $414.0K |
| Sales/maturities of investments | $70.2M | $0 | $20.5M | $258.4M | $11.3M |
| Share repurchases | $0 | $244.0K | $0 | — | — |
| Tax withholding on stock comp | $9.1M | $5.7M | $146.0K | $1.2M | $52.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding SRTA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-04-23 to 2026-09-24
Recent transactions
- Insiders have net sold 141,878 shares over the last 182 days, across 0 purchases and 8 sales.
- Most recent: Tomkiel Melissa M. (Co-CEO and General Counsel) — Grant / award of 177,858 shares on 2026-09-24.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)141,878 sh(8 txns)
Net Shares-141,878
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Tomkiel Melissa M. | Co-CEO and General Counsel | Grant / award | 2026-09-24 | 177,858 |
| Heyburn William A. | Co-CEO and CFO | Grant / award | 2026-09-24 | 177,858 |
| Verdetto Louis R. | CEO, Clinical Services | Tax withholding | 2026-09-08 | 5,697 |
| Wunsch Scott M | CEO, Logistics | Tax withholding | 2026-09-08 | 5,711 |
| Cohen Amir | Chief Accounting Officer | Tax withholding | 2026-09-08 | 4,645 |
| Love Reginald | Director | Open market sale | 2026-08-10 | 5,091 |
| Cook William L. III | Director | Grant / award | 2026-07-30 | 44,438 |
| PHILIP EDWARD M | Director | Grant / award | 2026-07-30 | 30,913 |
| WIESENTHAL ROBERT S | Director | Grant / award | 2026-07-30 | 50,234 |
| LAUCK ANDREW | Director | Grant / award | 2026-07-30 | 35,260 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-24 | Tomkiel Melissa M. | Co-CEO and General Counsel | Grant / award | 177,858 | $0.00 |
| 2026-09-24 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 90,797 | $5.27 |
| 2026-09-24 | Heyburn William A. | Co-CEO and CFO | Grant / award | 177,858 | $0.00 |
| 2026-09-24 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 98,356 | $5.27 |
| 2026-09-08 | Verdetto Louis R. | CEO, Clinical Services | Tax withholding | 5,697 | $5.31 |
| 2026-09-08 | Wunsch Scott M | CEO, Logistics | Tax withholding | 5,711 | $5.31 |
| 2026-09-08 | Cohen Amir | Chief Accounting Officer | Tax withholding | 4,645 | $5.31 |
| 2026-09-08 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 29,730 | $5.31 |
| 2026-09-08 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 31,671 | $5.31 |
| 2026-08-10 | Love Reginald | Director | Open market sale | 5,091 | $5.75 |
| 2026-07-31 | Wunsch Scott M | CEO, Logistics | Tax withholding | 13,992 | $5.09 |
| 2026-07-31 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 199,209 | $5.09 |
| 2026-07-31 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 212,309 | $5.09 |
| 2026-07-31 | Cohen Amir | Chief Accounting Officer | Tax withholding | 34,015 | $5.09 |
| 2026-07-30 | Cook William L. III | Director | Grant / award | 44,438 | $0.00 |
| 2026-07-30 | Love Reginald | Director | Grant / award | 37,675 | $0.00 |
| 2026-07-30 | PHILIP EDWARD M | Director | Grant / award | 30,913 | $0.00 |
| 2026-07-30 | WIESENTHAL ROBERT S | Director | Grant / award | 50,234 | $0.00 |
| 2026-07-30 | LAUCK ANDREW | Director | Grant / award | 35,260 | $0.00 |
| 2026-07-30 | Wunsch Scott M | CEO, Logistics | Grant / award | 57,172 | $0.00 |
| 2026-07-30 | Heyburn William A. | Co-CEO and CFO | Grant / award | 181,071 | $0.00 |
| 2026-07-30 | Heyburn William A. | Co-CEO and CFO | Grant / award | 179,160 | $0.00 |
| 2026-07-30 | Tomkiel Melissa M. | Co-CEO and General Counsel | Grant / award | 208,929 | $0.00 |
| 2026-07-30 | Tomkiel Melissa M. | Co-CEO and General Counsel | Grant / award | 206,953 | $0.00 |
| 2026-07-30 | Cohen Amir | Chief Accounting Officer | Grant / award | 41,786 | $0.00 |
| 2026-07-30 | Cohen Amir | Chief Accounting Officer | Grant / award | 27,420 | $0.00 |
| 2026-06-08 | Heyburn William A. | Co-CEO and CFO | Open market sale | 31,671 | $5.87 |
| 2026-06-08 | Cohen Amir | Chief Accounting Officer | Open market sale | 4,655 | $5.87 |
| 2026-06-08 | Tomkiel Melissa M. | Co-CEO and General Counsel | Open market sale | 29,730 | $5.87 |
| 2026-06-08 | Wunsch Scott M | CEO, Logistics | Open market sale | 5,550 | $5.87 |
| 2026-05-22 | Cohen Amir | Chief Accounting Officer | Open market sale | 40,575 | $5.91 |
| 2026-05-21 | Cohen Amir | Chief Accounting Officer | Open market sale | 10,300 | $5.79 |
| 2026-05-11 | Cohen Amir | Chief Accounting Officer | Open market sale | 14,306 | $5.79 |
| 2026-04-24 | Wunsch Scott M | CEO, Logistics | Tax withholding | 13,922 | $4.92 |
| 2026-04-23 | Wunsch Scott M | CEO, Logistics | Grant / award | 57,172 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:02 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-25 | 4 | 2026-09-24 | View on SEC.gov → |
| 2026-09-25 | 4 | 2026-09-24 | View on SEC.gov → |
| 2026-09-10 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-09-10 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-09-10 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-09-10 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-09-10 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-08-13 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-04 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-04 | 8-K | 2026-08-04 | View on SEC.gov → |
| 2026-08-03 | 4 | 2026-07-30 | View on SEC.gov → |
| 2026-08-03 | 4 | 2026-07-30 | View on SEC.gov → |
Recent news
Headlines about SRTA (Strata Critical Medical, Inc. Class A). Links open the publisher — we don’t host full articles.
-
Strata Critical Medical gains as activist Third Point takes stake, pushes for sale
Seeking Alpha · 2026-10-16 -
US Gap-Up and Gap-Down Stocks in the October 16, 2026 Session
ChartMill · 2026-10-16 -
Crude Oil Jumps 3%; Citizens Financial Earnings Top Views
Benzinga · 2026-10-16 -
Ladder Capital Posts Upbeat Q3 Earnings, Joins Alcoa, Hyster-Yale And Other Big Stocks Moving Higher On Friday
Benzinga · 2026-10-16 -
SRTA: Strata Critical Medical Inc Latest Stock Price, Analysis, News and Trading Ideas
Stocktwits · 2026-10-15 -
A shareholder says Strata Critical Medical (SRTA) should explore a potential sale.
Stock Titan · 2026-10-15 -
Third Point's Daniel Loeb Urges Strata Critical Medical To Explore Strategic Alternatives Including Potential Sale
Benzinga · 2026-10-15 -
Strata Critical Medical 13D Filing Shows Third Point Reports 5.8% Stake In Co. As Of Oct. 13
Benzinga · 2026-10-15
No headlines in this category right now — try “All”.